CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT

Blood ◽  
2013 ◽  
Vol 122 (19) ◽  
pp. 3359-3364 ◽  
Author(s):  
Martin Schmidt-Hieber ◽  
Myriam Labopin ◽  
Dietrich Beelen ◽  
Liisa Volin ◽  
Gerhard Ehninger ◽  
...  

Key Points Donor and/or recipient CMV seropositivity is still associated with an adverse prognosis in de novo acute leukemia patients after allo-SCT.

Sign in / Sign up

Export Citation Format

Share Document